TY - JOUR
T1 - The role of surgical lung biopsy in the diagnosis of fibrotic interstitial lung disease
T2 - Perspective from the pulmonary fibrosis foundation
AU - Hariri, Lida P.
AU - Roden, Anja C.
AU - Chung, Jonathan H.
AU - Danoff, Sonye K.
AU - Gomez Manjarres, Diana C.
AU - Hartwig, Matthew
AU - Kheir, Fayez
AU - King, Christopher
AU - Kreider, Maryl
AU - Lynch, David A.
AU - Mooney, Joshua
AU - Muniappan, Ashok
AU - Myers, Jeffrey L.
AU - Paoletti, Luca
AU - Raj, Rishi
AU - Zeenat, Zeenat
AU - Suliman, Sally
AU - Thavarajah, Krishna
AU - Lederer, David J.
AU - Rudell, Frederick L.
AU - Bianchi, Pauline
AU - Shea, Barry S.
AU - Ley, Brett
N1 - Publisher Copyright:
© 2021 by the American Thoracic Society.
PY - 2021/10
Y1 - 2021/10
N2 - Diagnosis of interstitial lung disease (ILD) requires a multidisciplinary discussion approach that includes clinicians, radiologists, and pathologists. Surgical lung biopsy (SLB) is currently the recommended standard in obtaining pathologic specimens for patients with ILD requiring a tissue diagnosis. The increased diagnostic confidence and accuracy provided by microscopic pathology assessment of SLB specimens must be balanced with the associated risks in patients with ILD. This document was developed by the SLB Working Group of the Pulmonary Fibrosis Foundation, composed of a multidisciplinary group of ILD physicians, including pulmonologists, radiologists, pathologists, and thoracic surgeons. In this document, we present an up-to-date literature review of the indications, contraindications, risks, and alternatives to SLB in the diagnosis of fibrotic ILD; outline an integrated approach to the decision-making around SLB in the diagnosis of fibrotic ILD; and provide practical information to maximize the yield and safety of SLB.
AB - Diagnosis of interstitial lung disease (ILD) requires a multidisciplinary discussion approach that includes clinicians, radiologists, and pathologists. Surgical lung biopsy (SLB) is currently the recommended standard in obtaining pathologic specimens for patients with ILD requiring a tissue diagnosis. The increased diagnostic confidence and accuracy provided by microscopic pathology assessment of SLB specimens must be balanced with the associated risks in patients with ILD. This document was developed by the SLB Working Group of the Pulmonary Fibrosis Foundation, composed of a multidisciplinary group of ILD physicians, including pulmonologists, radiologists, pathologists, and thoracic surgeons. In this document, we present an up-to-date literature review of the indications, contraindications, risks, and alternatives to SLB in the diagnosis of fibrotic ILD; outline an integrated approach to the decision-making around SLB in the diagnosis of fibrotic ILD; and provide practical information to maximize the yield and safety of SLB.
KW - Diagnostic guidelines
KW - Idiopathic pulmonary fibrosis
KW - Interstitial lung disease
KW - Surgical lung biopsy
KW - Usual interstitial pneumonitis
UR - http://www.scopus.com/inward/record.url?scp=85116213414&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116213414&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.202009-1179FR
DO - 10.1513/AnnalsATS.202009-1179FR
M3 - Review article
C2 - 34004127
AN - SCOPUS:85116213414
SN - 2329-6933
VL - 18
SP - 1601
EP - 1609
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 10
ER -